{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:51:22Z","timestamp":1784357482977,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biol"],"DOI":"10.1186\/s12915-025-02173-3","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:02:24Z","timestamp":1740960144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Switching of OAS1 splicing isoforms overcomes SNP-derived vulnerability to SARS-CoV-2 infection"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7130-8705","authenticated-orcid":false,"given":"Kei","family":"Iida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Ajiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Nakano-Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Muramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Takenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Denawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"2173_CR1","unstructured":"World Health Organization (WHO) WHO COVID-19 dashboard. https:\/\/covid19.who.int. Accessed 10 Jan 2024."},{"key":"2173_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","volume":"591","author":"E Pairo-Castineira","year":"2021","unstructured":"Pairo-Castineira E, Clohisey S, Klaric L, et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591:92\u20138.","journal-title":"Nature"},{"key":"2173_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","volume":"600","author":"COVID-19 Host Genetics Initiative","year":"2021","unstructured":"COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. 2021;600:472\u20137.","journal-title":"Nature"},{"key":"2173_CR4","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo D, Nilsson-Payant BE, Liu W, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036-1045.e9.","journal-title":"Cell"},{"key":"2173_CR5","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.bbrc.2005.02.101","volume":"329","author":"E Hamano","year":"2005","unstructured":"Hamano E, Hijikata M, Itoyama S, et al. Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population. Biochem Biophys Res Commun. 2005;329:1234\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2173_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1471-2334-6-106","volume":"6","author":"J He","year":"2006","unstructured":"He J, Feng D, de Vlas SJ, et al. Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study. BMC Infect Dis. 2006;6:106.","journal-title":"BMC Infect Dis"},{"key":"2173_CR7","doi-asserted-by":"publisher","first-page":"8035","DOI":"10.4049\/jimmunol.0902728","volume":"183","author":"R-J Lin","year":"2009","unstructured":"Lin R-J, Yu H-P, Chang B-L, Tang W-C, Liao C-L, Lin Y-L. Distinct antiviral roles for human 2\u2019,5\u2019-oligoadenylate synthetase family members against dengue virus infection. J Immunol. 2009;183:8035\u201343.","journal-title":"J Immunol"},{"key":"2173_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.humimm.2012.11.011","volume":"74","author":"S Noguchi","year":"2013","unstructured":"Noguchi S, Hamano E, Matsushita I, Hijikata M, Ito H, Nagase T, Keicho N. Differential effects of a common splice site polymorphism on the generation of OAS1 variants in human bronchial epithelial cells. Hum Immunol. 2013;74:395\u2013401.","journal-title":"Hum Immunol"},{"key":"2173_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2121-15-33","volume":"15","author":"KH Kj\u00e6r","year":"2014","unstructured":"Kj\u00e6r KH, Pahus J, Hansen MF, Poulsen JB, Christensen EI, Justesen J, Martensen PM. Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism. BMC Cell Biol. 2014;15:1\u201314.","journal-title":"BMC Cell Biol"},{"key":"2173_CR10","doi-asserted-by":"publisher","first-page":"17571","DOI":"10.1038\/s41598-017-17931-9","volume":"7","author":"X Liu","year":"2017","unstructured":"Liu X, Xing H, Gao W, et al. A functional variant in the OAS1 gene is associated with Sj\u00f6gren\u2019s syndrome complicated with HBV infection. Sci Rep. 2017;7:17571.","journal-title":"Sci Rep"},{"key":"2173_CR11","doi-asserted-by":"publisher","first-page":"e71047","DOI":"10.7554\/eLife.71047","volume":"10","author":"FW Soveg","year":"2021","unstructured":"Soveg FW, Schwerk J, Gokhale NS, et al. Endomembrane targeting of human OAS1 p46 augments antiviral activity. Elife. 2021;10:e71047.","journal-title":"Elife"},{"key":"2173_CR12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nri.2016.78","volume":"16","author":"M Schlee","year":"2016","unstructured":"Schlee M, Hartmann G. Discriminating self from non-self in nucleic acid sensing. Nat Rev Immunol. 2016;16:566\u201380.","journal-title":"Nat Rev Immunol"},{"key":"2173_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri2314","volume":"8","author":"AJ Sadler","year":"2008","unstructured":"Sadler AJ, Williams BRG. Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008;8:559\u201368.","journal-title":"Nat Rev Immunol"},{"key":"2173_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/v12020152","volume":"12","author":"H Di","year":"2020","unstructured":"Di H, Elbahesh H, Brinton MA. Characteristics of human OAS1 isoform proteins. Viruses. 2020;12:152.","journal-title":"Viruses"},{"key":"2173_CR15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.chom.2019.01.001","volume":"25","author":"CM Carey","year":"2019","unstructured":"Carey CM, Govande AA, Cooper JM, Hartley MK, Kranzusch PJ, Elde NC. Recurrent loss-of-function mutations reveal costs to OAS1 antiviral activity in primates. Cell Host Microbe. 2019;25:336-343.e4.","journal-title":"Cell Host Microbe"},{"key":"2173_CR16","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1093\/nar\/gkg616","volume":"31","author":"L Cartegni","year":"2003","unstructured":"Cartegni L. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 2003;31:3568\u201371.","journal-title":"Nucleic Acids Res"},{"key":"2173_CR17","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.chembiol.2020.08.013","volume":"27","author":"S Shibata","year":"2020","unstructured":"Shibata S, Ajiro M, Hagiwara M. Mechanism-Based Personalized Medicine for Cystic Fibrosis by Suppressing Pseudo Exon Inclusion. Cell Chem Biol. 2020;27:1472-1482.e6.","journal-title":"Cell Chem Biol"},{"key":"2173_CR18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.chom.2015.11.002","volume":"18","author":"S Tripathi","year":"2015","unstructured":"Tripathi S, Pohl MO, Zhou Y, et al. Meta- and orthogonal integration of influenza \u201cOMICs\u201d data defines a role for UBR4 in virus budding. Cell Host Microbe. 2015;18:723\u201335.","journal-title":"Cell Host Microbe"},{"key":"2173_CR19","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci"},{"key":"2173_CR20","doi-asserted-by":"publisher","first-page":"W521","DOI":"10.1093\/nar\/gkae241","volume":"52","author":"F Madeira","year":"2024","unstructured":"Madeira F, Madhusoodanan N, Lee J, Eusebi A, Niewielska A, Tivey ARN, Lopez R, Butcher S. The EMBL-EBI Job Dispatcher sequence analysis tools framework in 2024. Nucleic Acids Res. 2024;52:W521\u20135.","journal-title":"Nucleic Acids Res"},{"key":"2173_CR21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/bioinformatics\/btw643","volume":"33","author":"JH Marcus","year":"2017","unstructured":"Marcus JH, Novembre J. Visualizing the geography of genetic variants. Bioinformatics. 2017;33:594\u20135.","journal-title":"Bioinformatics"},{"key":"2173_CR22","doi-asserted-by":"publisher","first-page":"10268","DOI":"10.1073\/pnas.1704143114","volume":"114","author":"A Nakano-Kobayashi","year":"2017","unstructured":"Nakano-Kobayashi A, Awaya T, Kii I, Sumida Y, Okuno Y, Yoshida S, Sumida T, Inoue H, Hosoya T, Hagiwara M. Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice. Proc Natl Acad Sci. 2017;114:10268\u201373.","journal-title":"Proc Natl Acad Sci"},{"key":"2173_CR23","doi-asserted-by":"publisher","first-page":"eabc1428","DOI":"10.1126\/sciadv.abc1428","volume":"6","author":"A Nakano-Kobayashi","year":"2020","unstructured":"Nakano-Kobayashi A, Fukumoto A, Morizane A, et al. Therapeutics potentiating microglial p21-Nrf2 axis can rescue neurodegeneration caused by neuroinflammation. Sci Adv. 2020;6:eabc1428.","journal-title":"Sci Adv"},{"key":"2173_CR24","doi-asserted-by":"publisher","first-page":"eabj3624","DOI":"10.1126\/science.abj3624","volume":"374","author":"A Wickenhagen","year":"2021","unstructured":"Wickenhagen A, Sugrue E, Lytras S, et al. A prenylated dsRNA sensor protects against severe COVID-19. Science. 2021;374:eabj3624.","journal-title":"Science"},{"key":"2173_CR25","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41588-022-01113-z","volume":"54","author":"AR Banday","year":"2022","unstructured":"Banday AR, Stanifer ML, Florez-Vargas O, et al. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries. Nat Genet. 2022;54:1103\u201316.","journal-title":"Nat Genet"},{"key":"2173_CR26","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1038\/emm.2014.110","volume":"47","author":"UY Choi","year":"2015","unstructured":"Choi UY, Kang J-S, Hwang YS, Kim Y-J. Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp Mol Med. 2015;47:e144\u2013e144.","journal-title":"Exp Mol Med"},{"key":"2173_CR27","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.1093\/nar\/gkv389","volume":"43","author":"MS Ibsen","year":"2015","unstructured":"Ibsen MS, Gad HH, Andersen LL, Hornung V, Julkunen I, Sarkar SN, Hartmann R. Structural and functional analysis reveals that human OASL binds dsRNA to enhance RIG-I signaling. Nucleic Acids Res. 2015;43:5236\u201348.","journal-title":"Nucleic Acids Res"},{"key":"2173_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bbagrm.2010.01.010","volume":"1799","author":"E Ford","year":"2010","unstructured":"Ford E, Thanos D. The transcriptional code of human IFN-\u03b2 gene expression. Biochim et Biophysa Acta (BBA) - Gene Regul Mech. 2010;1799:328\u201336.","journal-title":"Biochim et Biophysa Acta (BBA) - Gene Regul Mech"},{"key":"2173_CR29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/v12070733","volume":"12","author":"H Schwanke","year":"2020","unstructured":"Schwanke H, Stempel M, Brinkmann MM. Of keeping and tipping the balance: host regulation and viral modulation of IRF3-dependent IFNB1 expression. Viruses. 2020;12:733.","journal-title":"Viruses"},{"key":"2173_CR30","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1056\/NEJMc2001899","volume":"382","author":"S Hoehl","year":"2020","unstructured":"Hoehl S, Rabenau H, Berger A, et al. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. N Engl J Med. 2020;382:1278\u201380.","journal-title":"N Engl J Med"},{"key":"2173_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/gcc.10268","volume":"38","author":"V Bezrookove","year":"2003","unstructured":"Bezrookove V, Smits R, Moeslein G, Fodde R, Tanke HJ, Raap AK, Darroudi F. Premature chromosome condensation revisited: a novel chemical approach permits efficient cytogenetic analysis of cancers. Genes Chrom Cancer. 2003;38:177\u201386.","journal-title":"Genes Chrom Cancer"},{"key":"2173_CR32","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3390\/v11121122","volume":"11","author":"S Skrivergaard","year":"2019","unstructured":"Skrivergaard S, Jensen MS, Rolander TB, Nguyen TBN, Bundgaard A, Nejsum LN, Martensen PM. The cellular localization of the p42 and p46 oligoadenylate synthetase 1 isoforms and their impact on mitochondrial respiration. Viruses. 2019;11:1122.","journal-title":"Viruses"},{"key":"2173_CR33","doi-asserted-by":"publisher","first-page":"e0140661","DOI":"10.1371\/journal.pone.0140661","volume":"10","author":"B Ebersole","year":"2015","unstructured":"Ebersole B, Petko J, Woll M, Murakami S, Sokolina K, Wong V, Stagljar I, L\u00fcscher B, Levenson R. Effect of C-Terminal S-palmitoylation on D2 dopamine receptor trafficking and stability. PLoS ONE. 2015;10:e0140661.","journal-title":"PLoS ONE"},{"key":"2173_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.devcel.2018.10.024","volume":"47","author":"AM Ernst","year":"2018","unstructured":"Ernst AM, Syed SA, Zaki O, et al. S-Palmitoylation sorts membrane cargo for anterograde transport in the golgi. Dev Cell. 2018;47:479-493.e7.","journal-title":"Dev Cell"},{"key":"2173_CR35","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","volume":"395","author":"IF-N Hung","year":"2020","unstructured":"Hung IF-N, Lung K-C, Tso EY-K, et al. Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. The Lancet. 2020;395:1695\u2013704.","journal-title":"The Lancet"},{"key":"2173_CR36","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(20)31101-6","volume":"395","author":"S Shalhoub","year":"2020","unstructured":"Shalhoub S. Interferon beta-1b for COVID-19. The Lancet. 2020;395:1670\u20131.","journal-title":"The Lancet"},{"key":"2173_CR37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S2213-2600(20)30511-7","volume":"9","author":"PD Monk","year":"2021","unstructured":"Monk PD, Marsden RJ, Tear VJ, et al. Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Respir Med. 2021;9:196\u2013206.","journal-title":"Lancet Respir Med"},{"key":"2173_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cytogfr.2020.05.002","volume":"53","author":"SH Nile","year":"2020","unstructured":"Nile SH, Nile A, Qiu J, Li L, Jia X, Kai G. COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 2020;53:66\u201370.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2173_CR39","doi-asserted-by":"publisher","first-page":"e2026309118","DOI":"10.1073\/pnas.2026309118","volume":"118","author":"H Zeberg","year":"2021","unstructured":"Zeberg H, P\u00e4\u00e4bo S. A genomic region associated with protection against severe COVID-19 is inherited from Neandertals. Proc Natl Acad Sci. 2021;118:e2026309118.","journal-title":"Proc Natl Acad Sci"},{"key":"2173_CR40","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41591-021-01281-1","volume":"27","author":"S Zhou","year":"2021","unstructured":"Zhou S, Butler-Laporte G, Nakanishi T, et al. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity. Nat Med. 2021;27:659\u201367.","journal-title":"Nat Med"},{"key":"2173_CR41","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/molbev\/mst004","volume":"30","author":"FL Mendez","year":"2013","unstructured":"Mendez FL, Watkins JC, Hammer MF. Neandertal origin of genetic variation at the cluster of OAS immunity genes. Mol Biol Evol. 2013;30:798\u2013801.","journal-title":"Mol Biol Evol"},{"key":"2173_CR42","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1038\/s41467-021-26287-8","volume":"12","author":"M Ajiro","year":"2021","unstructured":"Ajiro M, Awaya T, Kim YJ, et al. Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia. Nat Commun. 2021;12:6039.","journal-title":"Nat Commun"},{"key":"2173_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12867-015-0044-6","volume":"16","author":"M Sakuma","year":"2015","unstructured":"Sakuma M, Iida K, Hagiwara M. Deciphering targeting rules of splicing modulator compounds: case of TG003. BMC Mol Biol. 2015;16:16.","journal-title":"BMC Mol Biol"},{"key":"2173_CR44","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"2173_CR45","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas.2002589117","volume":"117","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama S, Nao N, Shirato K, et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci. 2020;117:7001\u20133.","journal-title":"Proc Natl Acad Sci"}],"container-title":["BMC Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-025-02173-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12915-025-02173-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-025-02173-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:02:27Z","timestamp":1740960147000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiol.biomedcentral.com\/articles\/10.1186\/s12915-025-02173-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2173"],"URL":"https:\/\/doi.org\/10.1186\/s12915-025-02173-3","relation":{},"ISSN":["1741-7007"],"issn-type":[{"value":"1741-7007","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any content that requires ethical approval or consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This article does not contain any content that requires consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.H. is a founder, shareholder, and member of the scientific advisory board of KinoPharma, Inc., and BTB Drug Development Research Center Co., Ltd. This work has been filed for a world patent application (WO2022\/255411 A1); M.H., K.I., and T.N. are named as co-inventors. The authors have no other competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}